Hainan Shuangcheng Pharmaceuticals Management
Management criteria checks 4/4
We currently do not have sufficient information about the CEO.
Key information
Jianming Li
Chief executive officer
CN¥828.0k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 5yrs |
| CEO ownership | 0.4% |
| Management average tenure | 2yrs |
| Board average tenure | 5yrs |
Recent management updates
Recent updates
Hainan Shuangcheng Pharmaceuticals Co., Ltd.'s (SZSE:002693) Popularity With Investors Under Threat As Stock Sinks 30%
Dec 22
Is Hainan Shuangcheng Pharmaceuticals (SZSE:002693) Using Too Much Debt?
Nov 27Subdued Growth No Barrier To Hainan Shuangcheng Pharmaceuticals Co., Ltd.'s (SZSE:002693) Price
Aug 03Getting In Cheap On Hainan Shuangcheng Pharmaceuticals Co., Ltd. (SZSE:002693) Is Unlikely
Apr 15CEO
Jianming Li (68 yo)
5yrs
Tenure
CN¥828,000
Compensation
Mr. Jianming Li serves as an General Manager of Hainan Shuangcheng Pharmaceutical Co., Ltd. and serves as its Non-Independent director since January 16, 2020. He served as Executive Deputy General Manager...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Non-Independent Director | no data | CN¥828.00k | 0.42% CN¥ 22.9m | |
| Financial Director & Chief Financial Officer | 14.2yrs | CN¥380.00k | 0.17% CN¥ 9.1m | |
| Deputy GM & Secretary of the Board | 14.2yrs | CN¥380.00k | 0.16% CN¥ 8.7m | |
| Deputy General Manager | no data | CN¥494.80k | 0.15% CN¥ 8.1m | |
| Deputy General Manager | 2yrs | CN¥833.20k | 0.078% CN¥ 4.2m | |
| Deputy General Manager | 2yrs | CN¥367.40k | 0.030% CN¥ 1.6m | |
| Deputy General Manager | 2yrs | CN¥362.80k | 0.017% CN¥ 940.9k | |
| Deputy General Manager | 2yrs | CN¥332.60k | 0.013% CN¥ 709.5k | |
| Deputy General Manager | 2yrs | CN¥332.20k | 0.015% CN¥ 811.9k | |
| Deputy General Manager | 2yrs | CN¥362.30k | 0.016% CN¥ 862.9k | |
| Accounting Supervisor | no data | no data | no data |
2.0yrs
Average Tenure
45yo
Average Age
Experienced Management: 002693's management team is considered experienced (2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Non-Independent Director | 5yrs | CN¥828.00k | 0.42% CN¥ 22.9m | |
| Chairman | 14.2yrs | no data | 32.92% CN¥ 1.8b | |
| Vice Chairman | 14.2yrs | CN¥796.00k | 15.58% CN¥ 844.3m | |
| Non-Employee Supervisor | 14.2yrs | no data | no data | |
| Vice Chairman | 3yrs | no data | no data | |
| Chairman of the Supervisory Board | 7.9yrs | no data | no data | |
| Independent Director | 2yrs | CN¥60.00k | no data | |
| Independent Director | 2yrs | CN¥60.00k | no data | |
| Non-Employee Supervisor | 2yrs | no data | no data |
5.0yrs
Average Tenure
48yo
Average Age
Experienced Board: 002693's board of directors are considered experienced (5 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/31 04:18 |
| End of Day Share Price | 2025/01/27 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Hainan Shuangcheng Pharmaceuticals Co., Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jie Yao | Everbright Securities Co. Ltd. |
| Yun Li | Guodu Securities Co. |